List
The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
-
Microcapillary Quartz Sensors for Screening Injectability of High Concentration Protein Formulations
SBC: Qatch Technologies, LLC Topic: NoneThe objective of this SBIR Phase I proposal is to determine the feasibility of viscosity characterization of high concentration protein formulations (HCF) by QATCH’s microcapillary quartz technology. HCFs are non-Newtonian fluids with shear-thinning behavior and they are administered to patients by subcutaneous or muscular injections. The injectability of HCFs depends on the viscosity at high-sh ...
SBIR Phase I 2019 Department of CommerceNational Institute of Standards and Technology -
Nanomachine Device for Semiconductor Process Control Monitoring
SBC: Xallent LLC Topic: NoneConventional characterization and test methods are increasingly ineffective when applied to structures less than 100 nanometers, causing challenges across R&D, process control and failure analysis. An increasing number of subtle defects become prominent drivers of failure as device size and operating margins decrease, e.g., processing anomalies in thin gate oxides, substrate problems related to do ...
SBIR Phase I 2019 Department of CommerceNational Institute of Standards and Technology -
TOPIC 363: myCare2- Supporting Caregivers and Caregiving
SBC: BRIGHTOUTCOME INC. Topic: NCIThe myCare2 solution will be marketed to cancer care organizations and include three separate portals for cancer caregivers, patients and providers. The system will be mobile-enabled and support standards-based EHR integration. Primary myCare2 features include symptom assessment, communication with the care team, care plan dissemination, tailored education content for caregiving and for caregiver ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
TOPIC 356: FLOUROGENIC ASSAY PLATFORM FOR CIRCULAR RNA DETECTION
SBC: Lucerna Inc. Topic: NCICircular RNAs (circRNAs) are a novel class of non-coding RNAs that are an abundant component of the epitranscriptome. Putative functions of circRNAs, include miRNA sequestration, RNA-binding protein scaffolding, mRNA trapping, and protein translation regulation. Deregulation in one or more of these roles has been linked to several types of cancer, including pancreatic cancer, basal cell carcinoma, ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 374: Topical Delivery of Nanoformulated Bioactive Chemopreventive Agent in Skin Cancer
SBC: VASCULAR VISION PHARMACEUTICAL CO Topic: NCIWe plan to evaluate the chemopreventive management of solar ultraviolet (UV) mediated DNA damage by two different Nanoformulation of epigallicatechin-3-gallate (EGCG). The formulations to be assessed under this study include: a) chitosan based formulation of EGCG (nano-EGCG), and b) EGCG containing chitosan based solid lipid nanoparticles (E-Ch-SLNPs). EGCG is well-tested and popular polyphenol in ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 377: Enabling Clinical Decision Support for Guideline Based Cancer Symptom Management
SBC: KLESIS, LLC Topic: NCIThe objective of this proposal is to develop an electronic, rule-based clinical decision support system (CDS-Sx) that leverages national clinical practice guidelines (CPGs) to improve cancer symptom management. Specific tasks that will be performed include: 1) create software-ready computable algorithms for managing cancer-related fatigue and constipation that have been vetted with diverse cancer ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 341: Open Scalable Software Infrastructure for Metabolomics Data
SBC: Kitware, Inc. Topic: NCIMetabolomics research has great potential, and researchers are rapidly producing new techniques for analyzing the large quantities of measurement data in order to utilize metabolomic data more effectively, including promising techniques for data integration across multiple modalities of data from mass spectrometry (MS) and nuclear magnetic resonance (NMR). However, this confluence of data growth a ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 374: Targeted and Sustained Release Microparticles for Colon Cancer Chemoprevention
SBC: Zymeron Corporation Topic: NCIColorectal Cancer (CRC) is the third most common cancer both in men and women, as well as the second leading cause of cancer deaths with an estimated 135,430 new cases diagnosed and 50,260 deaths for 2017 in the United States. Given the limitations of screening tests and poor prognosis associated with advanced stage colorectal cancer, it would be of great interest in exploring chemoprevention stra ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
The objective of this contract is to develop an HIV latent reservoir assay using a microwell array consumable.
SBC: Cell Microsystems, Inc. Topic: NIAIDA critical remaining challenge toward a true cure for HIV is understanding how latently infected cells evade the immune system and persist as lifelong viral reservoirsOne eradication strategythe so calledshock and killapproachrelies on cell activating compounds to reverse latent infectionand subsequent antiretroviral therapy to eradicate newly activated cellsHoweverthese compounds activate only a ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Assay optimization and adaptation for a customized meter development
SBC: GlucoSentient, Inc Topic: NIAIDInvasive fungal infectionsIFIcaused by ubiquitous mold and yeast is a common cause of negative health outcomes for immunocompromised patientsincluding patients undergo solid organ transplantSOTand hematopoietic stem cell transplantHSCTregularly leading to events such as organ failure or deathCurrent methods for screening IFI rely on laboratory tests that require specialized equipment and professio ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health